Is Yeztugo Available? Access and Information on the Twice-Yearly HIV Prevention Shot
•
2 min read
Following its FDA approval in June 2025, Yeztugo (lenacapavir) became the first and only twice-yearly injectable option for HIV pre-exposure prophylaxis (PrEP) in the United States. For those asking, 'Is Yeztugo available?', the answer is yes in the United States, representing a significant advancement in HIV prevention by simplifying the dosing schedule and addressing adherence barriers.
